Annual report pursuant to Section 13 and 15(d)

Collaboration and Research Arrangements - Summary of Changes in Contract Assets and Liabilities (Details)

v3.24.1
Collaboration and Research Arrangements - Summary of Changes in Contract Assets and Liabilities (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2023
USD ($)
Disaggregation Of Revenue [Line Items]  
Contract liabilities, Balance at Beginning of Period $ 4,330
Contract liabilities, Deduction 4,330
Global Blood Therapeutics  
Disaggregation Of Revenue [Line Items]  
Contract liabilities, Balance at Beginning of Period 4,330
Contract liabilities, Deduction $ 4,330